Siemens Healthineers on Monday announced an agreement to distribute Scopio Labs’ full-field digital cell morphology technology, which will enable clinical laboratorians to examine patient blood cell samples digitally instead of under a microscope.
Financial and other terms of the agreement were not disclosed.
Erlangen, Germany-based Siemens Healthineers said the Scopio X100 and Scopio X100HT imaging platforms will complement its IVD systems, including the Atellica Hema 570 and Atellica Hema 580 analyzers.
By combining Siemens Healthineers and Scopio products, labs will obtain high-resolution, full-field viewing for peripheral blood specimens and artificial intelligence-based morphological analysis with remote capabilities through the secure hospital network, Siemens Healthineers said.
“By offering laboratorians access to novel digital hematology technologies in one of the lab’s busiest testing disciplines, we will be providing critical tools to optimize operational workflow and laboratory efficiency, accelerate diagnosis, and improve patient care while addressing reduced resource capacity,” Sharon Bracken, head of diagnostics at Siemens Healthineers, said in an interview. “The alliance between Siemens Healthineers and Scopio Labs is a step forward in delivering automated and digitized solutions that would redefine hematology workflow.”
The Scopio digital cell morphology platforms are intended for use in the central laboratory adjacent to hematology analyzers to examine patient blood cell samples digitally and remotely, instead of on a slide under a microscope. A patient sample is run on a hematology analyzer. When abnormalities in a patient blood sample are detected or further analysis is required, a blood smear is prepared, and the slide is transferred to the Scopio imaging platform for digitalization.
Traditional manual microscopy requires specialized laboratory staff to examine slides and is time-consuming due to the volume of testing and the scope of analysis required for abnormal patient samples. Attempts to digitize cell samples have often faced a tradeoff — increasing resolution versus field of view — both of which contain essential clinical information pertinent for patient care.
Scopio Labs’ full-field imaging technology provides both the clinical big picture and the smallest details of a cell at the same time, Siemens Healthineers noted.
Integrated artificial intelligence (AI) decision support gives laboratory professionals an efficient way to standardize WBC differentials, RBC blood morphology, and platelet estimations. Remote review capabilities mean laboratory professional expertise will no longer be limited by physical location, and healthcare networks can provide fast analyses for their patients while better managing professional resources at their institutions.
Scopio’s Full-Field Peripheral Blood Smear Application has been shown to reduce turnaround time for peripheral blood smear review by 60%, Siemens Healthineers said.